Overview
Margo Dona practices in Nijmegen, Netherlands. Ms. Dona is rated as an Advanced expert by MediFind in the treatment of Mitochondrial Complex 2 Deficiency. Her top areas of expertise are Retinopathy Pigmentary Mental Retardation, Usher Syndrome, Retinitis Pigmentosa, and Mitochondrial Complex 2 Deficiency.
Her clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Mitochondrial Complex 2 Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Retinopathy Pigmentary Mental Retardation
- Advanced
- Mitochondrial Complex 2 Deficiency
- PheochromocytomaMs. Dona isAdvanced. Learn about Pheochromocytoma.
- Retinitis PigmentosaMs. Dona isAdvanced. Learn about Retinitis Pigmentosa.
- Usher SyndromeMs. Dona isAdvanced. Learn about Usher Syndrome.
- Experienced
- Adrenal CancerMs. Dona isExperienced. Learn about Adrenal Cancer.
- Cystic FibrosisMs. Dona isExperienced. Learn about Cystic Fibrosis.
- Hearing LossMs. Dona isExperienced. Learn about Hearing Loss.
- Late-Onset Retinal DegenerationMs. Dona isExperienced. Learn about Late-Onset Retinal Degeneration.
- Neuroendocrine TumorMs. Dona isExperienced. Learn about Neuroendocrine Tumor.
- Usher Syndrome Type 2AMs. Dona isExperienced. Learn about Usher Syndrome Type 2A.